These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21732820)

  • 1. Publics and vaccinomics: beyond public understanding of science.
    Einsiedel EF
    OMICS; 2011 Sep; 15(9):607-14. PubMed ID: 21732820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-first century vaccinomics innovation systems: capacity building in the global South and the role of Product Development Partnerships (PDPs).
    Huzair F; Borda-Rodriguez A; Upton M
    OMICS; 2011 Sep; 15(9):539-43. PubMed ID: 21732822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic testing for vaccinomics: is the regulatory approval framework adequate? A comparison of Canada, the United States, and Europe.
    Joly Y; Koutrikas G; Ramos-Paque E; Zawati M; Gardy J; Hayden MR; Carleton BC
    OMICS; 2011 Sep; 15(9):597-605. PubMed ID: 21728814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines of the 21st century and vaccinomics: data-enabled science meets global health to spark collective action for vaccine innovation.
    Ozdemir V; Pang T; Knoppers BM; Avard D; Faraj SA; Zawati MH; Kolker E
    OMICS; 2011 Sep; 15(9):523-7. PubMed ID: 21848418
    [No Abstract]   [Full Text] [Related]  

  • 5. Steering vaccinomics innovations with anticipatory governance and participatory foresight.
    Ozdemir V; Faraj SA; Knoppers BM
    OMICS; 2011 Sep; 15(9):637-46. PubMed ID: 21848419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical and policy implications of vaccinomics in the United States: community members' perspectives.
    Gerber JE; Brewer J; Limaye RJ; Sutherland A; Geller G; Spina CI; Salmon DA
    Hum Vaccin Immunother; 2021 Jul; 17(7):2133-2144. PubMed ID: 33626296
    [No Abstract]   [Full Text] [Related]  

  • 7. An overview of the role of society and risk in xenotransplantation.
    Sobbrio P; Jorqui M
    Xenotransplantation; 2014; 21(6):523-32. PubMed ID: 25040770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constructing the public in public perceptions research: A case study of forest genomics.
    Berseth V; Taylor J; Hutchen J; Nguyen V; Schott S; Klenk N
    Public Underst Sci; 2024 May; 33(4):483-503. PubMed ID: 38095191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental findings in data-intensive postgenomics science and legal liability of clinician-researchers: ready for vaccinomics?
    Zawati MH; Hendy M; Joly Y
    OMICS; 2011 Sep; 15(9):615-24. PubMed ID: 21728813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
    Andrus JK; Lewis MJ; Goldie SJ; García PJ; Winkler JL; Ruiz-Matus C; de Quadros CA
    Vaccine; 2008 Aug; 26 Suppl 11():L80-7. PubMed ID: 18945405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine mandates are justifiable because we are all in this together.
    Lantos JD; Jackson MA
    Am J Bioeth; 2013; 13(9):1-2. PubMed ID: 23952821
    [No Abstract]   [Full Text] [Related]  

  • 12. Designing the next generation of vaccines for global public health.
    Bagnoli F; Baudner B; Mishra RP; Bartolini E; Fiaschi L; Mariotti P; Nardi-Dei V; Boucher P; Rappuoli R
    OMICS; 2011 Sep; 15(9):545-66. PubMed ID: 21682594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.
    Poland GA; Ovsyannikova IG; Kennedy RB; Haralambieva IH; Jacobson RM
    OMICS; 2011 Sep; 15(9):625-36. PubMed ID: 21732819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned in the analysis of high-dimensional data in vaccinomics.
    Oberg AL; McKinney BA; Schaid DJ; Pankratz VS; Kennedy RB; Poland GA
    Vaccine; 2015 Sep; 33(40):5262-70. PubMed ID: 25957070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and High-Consequence Infectious Diseases: A Scoping Review of Emerging Science and Potential Ethical Issues.
    Boyce AM; Garibaldi BT
    Health Secur; 2019; 17(1):62-68. PubMed ID: 30724614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public knowledge and public trust.
    Cunningham-Burley S
    Community Genet; 2006; 9(3):204-10. PubMed ID: 16741351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A crisis of public confidence in vaccines.
    Black S; Rappuoli R
    Sci Transl Med; 2010 Dec; 2(61):61mr1. PubMed ID: 21148125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a manifesto for the 'public understanding of big data'.
    Michael M; Lupton D
    Public Underst Sci; 2016 Jan; 25(1):104-16. PubMed ID: 26468128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use.
    Levine MM; Levine OS
    Lancet; 1997 Nov; 350(9088):1386-92. PubMed ID: 9365466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine research, development, and innovation in Brazil: a translational science perspective.
    Homma A; Tanuri A; Duarte AJ; Marques E; de Almeida A; Martins R; Silva-Junior JB; Possas C
    Vaccine; 2013 Apr; 31 Suppl 2():B54-60. PubMed ID: 23598493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.